32426546|t|Tualang honey supplementation as cognitive enhancer in patients with schizophrenia.
32426546|a|INTRODUCTION: Schizophrenia is a chronic mental illness with clusters of symptoms, including cognitive impairment. This study aimed to explore the effect of Tualang Honey (TH) on cognitive domains, especially as it pertained to the verbal memory of schizophrenia patients. METHOD: This was a cross-sectional study involved 80 individuals, diagnosed with schizophrenia. The Malay Version Auditory Verbal Learning Test (MVAVLT) was used. Data were analysed using SPSS 20.0 software. Intention to treat analysis was applied. RESULT: A comparison of the total learning score at eight weeks between the two groups based on time effect and time-treatment interaction favoured TH group. CONCLUSION: This study concludes that by supplementing schizophrenia patients with 8-week of TH did improve total learning performance across domains in the immediate memory among patients with schizophrenia.
32426546	0	13	Tualang honey	Chemical	-
32426546	55	63	patients	Species	9606
32426546	69	82	schizophrenia	Disease	MESH:D012559
32426546	98	111	Schizophrenia	Disease	MESH:D012559
32426546	125	139	mental illness	Disease	MESH:D001523
32426546	177	197	cognitive impairment	Disease	MESH:D003072
32426546	241	254	Tualang Honey	Chemical	-
32426546	256	258	TH	Chemical	-
32426546	333	346	schizophrenia	Disease	MESH:D012559
32426546	347	355	patients	Species	9606
32426546	438	451	schizophrenia	Disease	MESH:D012559
32426546	754	756	TH	Chemical	-
32426546	819	832	schizophrenia	Disease	MESH:D012559
32426546	833	841	patients	Species	9606
32426546	857	859	TH	Chemical	-
32426546	944	952	patients	Species	9606
32426546	958	971	schizophrenia	Disease	MESH:D012559

